Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sharon Pine

Concepts (317)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
32
2025
2664
2.890
 Why?
Carcinoma, Non-Small-Cell Lung
10
2025
1188
1.470
 Why?
Amyloid Precursor Protein Secretases
3
2018
78
1.130
 Why?
Biomarkers, Tumor
12
2025
1321
1.130
 Why?
SOX9 Transcription Factor
3
2023
27
1.100
 Why?
Leukemia, Megakaryoblastic, Acute
4
2007
10
0.800
 Why?
Receptor, Notch1
2
2014
63
0.790
 Why?
GATA1 Transcription Factor
4
2007
18
0.760
 Why?
DNA, Neoplasm
4
2010
158
0.710
 Why?
Janus Kinases
1
2021
21
0.700
 Why?
STAT Transcription Factors
1
2021
25
0.700
 Why?
Paclitaxel
2
2022
256
0.650
 Why?
Signal Transduction
9
2021
5202
0.620
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
2005
296
0.620
 Why?
Carcinoma, Squamous Cell
4
2025
644
0.620
 Why?
Neoplastic Stem Cells
3
2013
409
0.570
 Why?
Inflammation
4
2022
2883
0.550
 Why?
Protease Inhibitors
1
2018
101
0.540
 Why?
Benzodiazepinones
1
2017
18
0.530
 Why?
Gene Expression Regulation, Neoplastic
9
2025
1439
0.520
 Why?
Neoplasms
4
2025
2897
0.510
 Why?
Cell Line, Tumor
13
2023
3537
0.500
 Why?
Antineoplastic Agents
7
2023
2207
0.490
 Why?
Down Syndrome
4
2007
525
0.490
 Why?
F-Box Proteins
1
2016
23
0.480
 Why?
Antineoplastic Agents, Phytogenic
1
2017
177
0.480
 Why?
Oncogene Proteins, Fusion
4
2017
212
0.480
 Why?
Polymerase Chain Reaction
6
2010
1049
0.480
 Why?
Proteasome Endopeptidase Complex
1
2016
153
0.450
 Why?
Drug Resistance, Neoplasm
6
2021
881
0.440
 Why?
Interleukin-8
3
2014
269
0.440
 Why?
Ubiquitin-Protein Ligases
1
2016
191
0.430
 Why?
Neoplasms, Basal Cell
1
2013
4
0.410
 Why?
Chromosome Segregation
1
2013
48
0.400
 Why?
DNA Damage
1
2016
434
0.390
 Why?
DNA
2
2022
1451
0.360
 Why?
Cell Cycle Proteins
1
2016
631
0.360
 Why?
Interleukin-6
3
2019
772
0.360
 Why?
C-Reactive Protein
2
2011
422
0.350
 Why?
Adenocarcinoma
3
2017
923
0.340
 Why?
Mannose-Binding Lectin
2
2009
20
0.340
 Why?
Smoking
6
2024
1468
0.330
 Why?
Proto-Oncogene Proteins c-mdm2
2
2012
67
0.320
 Why?
Humans
53
2025
145491
0.320
 Why?
Case-Control Studies
14
2024
3619
0.310
 Why?
Cell Transformation, Neoplastic
2
2021
337
0.310
 Why?
Mutation
9
2023
4093
0.300
 Why?
Polymorphism, Single Nucleotide
6
2019
2146
0.290
 Why?
Mice
12
2023
18338
0.280
 Why?
Polymorphism, Genetic
2
2009
616
0.280
 Why?
Cytokines
1
2015
2054
0.270
 Why?
Inflammation Mediators
2
2021
505
0.260
 Why?
Proto-Oncogene Proteins p21(ras)
3
2023
254
0.260
 Why?
Lymphoma, AIDS-Related
1
2007
14
0.260
 Why?
Molecular Targeted Therapy
2
2021
439
0.250
 Why?
Lymphoproliferative Disorders
1
2007
57
0.250
 Why?
Leukemia
2
2007
246
0.250
 Why?
Animals
14
2023
38141
0.240
 Why?
Lymphoma, Non-Hodgkin
1
2007
124
0.230
 Why?
Nuclear Weapons
1
2025
7
0.230
 Why?
Cell Proliferation
7
2021
2499
0.230
 Why?
Base Sequence
5
2014
2180
0.220
 Why?
Neoplasms, Radiation-Induced
1
2025
100
0.220
 Why?
Female
32
2025
78763
0.210
 Why?
Carboplatin
2
2022
161
0.200
 Why?
Breast Neoplasms
2
2013
2373
0.200
 Why?
Smokers
1
2024
137
0.200
 Why?
Genes, ras
1
2023
96
0.190
 Why?
Tumor Microenvironment
3
2023
737
0.190
 Why?
Molecular Sequence Data
4
2014
2910
0.190
 Why?
Chromosomes, Human, Pair 19
1
2002
27
0.190
 Why?
Aged
19
2024
26125
0.190
 Why?
Central Nervous System Neoplasms
1
2005
177
0.180
 Why?
Alternative Splicing
1
2025
247
0.180
 Why?
Chromosomes, Human, Pair 1
1
2002
80
0.180
 Why?
Translocation, Genetic
1
2002
119
0.180
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
108
0.180
 Why?
Epithelial-Mesenchymal Transition
2
2014
211
0.180
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
456
0.180
 Why?
Cell Movement
3
2020
961
0.170
 Why?
Pyrazines
1
2022
93
0.170
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2022
138
0.170
 Why?
Ribosome Subunits, Large, Eukaryotic
1
2021
3
0.170
 Why?
Superoxide Dismutase-1
1
2021
10
0.170
 Why?
Organelle Biogenesis
1
2021
14
0.170
 Why?
Immunity, Innate
1
2007
846
0.170
 Why?
Cytokinesis
1
2021
50
0.170
 Why?
Triazoles
1
2022
184
0.170
 Why?
Adenocarcinoma, Mucinous
1
2021
76
0.160
 Why?
Male
26
2025
72817
0.160
 Why?
Middle Aged
18
2024
36176
0.160
 Why?
Phosphatidylinositol 3-Kinases
1
2022
380
0.160
 Why?
Receptors, Kisspeptin-1
1
2020
2
0.160
 Why?
Proto-Oncogene Proteins c-akt
1
2022
436
0.160
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2019
9
0.160
 Why?
Prognosis
7
2024
4323
0.160
 Why?
Disease Susceptibility
1
2021
343
0.150
 Why?
Janus Kinase 2
1
2019
29
0.150
 Why?
Molecular Chaperones
1
2021
182
0.150
 Why?
Mice, Inbred NOD
2
2020
613
0.150
 Why?
Cellular Senescence
2
2013
225
0.150
 Why?
Cellular Reprogramming
1
2020
99
0.150
 Why?
TOR Serine-Threonine Kinases
1
2022
452
0.140
 Why?
Neoplasm, Residual
3
2005
143
0.140
 Why?
Biomarkers
2
2021
4283
0.140
 Why?
Acrylamides
1
2019
74
0.140
 Why?
Combined Modality Therapy
1
2021
1269
0.140
 Why?
Nanotechnology
1
2019
121
0.140
 Why?
Homeodomain Proteins
1
2002
525
0.140
 Why?
Immunoglobulin Heavy Chains
3
2003
86
0.140
 Why?
Aniline Compounds
1
2019
122
0.140
 Why?
Proteolysis
2
2016
170
0.140
 Why?
Carcinogenesis
1
2020
227
0.130
 Why?
Quinolines
1
2019
193
0.130
 Why?
Risk Factors
8
2015
10874
0.130
 Why?
Receptors, Notch
1
2018
91
0.130
 Why?
Quinazolines
1
2019
266
0.130
 Why?
Transfection
2
2017
925
0.130
 Why?
Transcriptome
1
2024
1038
0.130
 Why?
Tumor Suppressor Protein p53
2
2013
536
0.130
 Why?
Lung
4
2022
4103
0.130
 Why?
Disease Management
1
2021
654
0.130
 Why?
CD24 Antigen
2
2013
18
0.130
 Why?
Triple Negative Breast Neoplasms
1
2020
218
0.120
 Why?
F-Box-WD Repeat-Containing Protein 7
1
2016
6
0.120
 Why?
Neoplasm Invasiveness
2
2020
505
0.120
 Why?
Cancer Survivors
1
2022
336
0.120
 Why?
Glycogen Synthase Kinase 3 beta
1
2016
73
0.120
 Why?
Hyaluronan Receptors
2
2013
105
0.120
 Why?
Ubiquitination
1
2016
118
0.120
 Why?
Coculture Techniques
2
2013
246
0.120
 Why?
Proportional Hazards Models
2
2011
1332
0.120
 Why?
Protein Interaction Domains and Motifs
1
2016
146
0.110
 Why?
Cell Division
3
2013
753
0.110
 Why?
Proto-Oncogene Proteins B-raf
1
2017
224
0.110
 Why?
Receptors, Interleukin-8B
1
2014
29
0.110
 Why?
Cell Death
1
2016
383
0.110
 Why?
Protein Isoforms
2
2013
396
0.110
 Why?
Tumor Cells, Cultured
2
2021
883
0.110
 Why?
Computational Biology
1
2019
687
0.110
 Why?
Protein Kinase Inhibitors
2
2019
980
0.100
 Why?
Gene Expression Profiling
4
2025
1769
0.100
 Why?
Patient Selection
1
2018
742
0.100
 Why?
3' Untranslated Regions
1
2014
150
0.100
 Why?
Software
1
2019
698
0.100
 Why?
Disease Progression
1
2021
2862
0.100
 Why?
Energy Metabolism
1
2020
932
0.100
 Why?
Ultraviolet Rays
1
2016
384
0.100
 Why?
Platinum Compounds
1
2013
11
0.100
 Why?
Genes, T-Cell Receptor
2
2003
6
0.100
 Why?
Colorectal Neoplasms
1
2021
866
0.100
 Why?
Research Design
2
2011
1134
0.100
 Why?
Dipeptides
1
2013
56
0.100
 Why?
Core Binding Factor Alpha 2 Subunit
2
2003
30
0.100
 Why?
Models, Biological
2
2019
1815
0.090
 Why?
Gene Expression Regulation
1
2021
2594
0.090
 Why?
Lymphocytes, Tumor-Infiltrating
1
2013
153
0.090
 Why?
Alleles
3
2014
893
0.090
 Why?
Survival Analysis
2
2013
1374
0.090
 Why?
Stromal Cells
1
2012
120
0.090
 Why?
Gap Junctions
1
2012
67
0.090
 Why?
Phosphorylation
1
2016
1707
0.090
 Why?
Genotype
4
2014
1853
0.090
 Why?
HIV Infections
1
2007
3189
0.080
 Why?
National Cancer Institute (U.S.)
1
2011
54
0.080
 Why?
Bone Marrow Cells
1
2012
321
0.080
 Why?
Infant
4
2007
10064
0.080
 Why?
Risk Assessment
3
2011
3759
0.080
 Why?
Japan
2
2025
147
0.080
 Why?
Cell Communication
1
2012
326
0.080
 Why?
Melanoma
1
2017
759
0.080
 Why?
Protein Binding
1
2016
2250
0.080
 Why?
ROC Curve
2
2024
619
0.080
 Why?
AC133 Antigen
1
2010
20
0.080
 Why?
Bromodeoxyuridine
1
2010
77
0.080
 Why?
Adult
8
2020
40707
0.080
 Why?
Phenotype
3
2013
3157
0.080
 Why?
Biopsy
2
2017
1081
0.070
 Why?
Logistic Models
2
2011
2130
0.070
 Why?
Exons
2
2008
363
0.070
 Why?
Genetic Predisposition to Disease
4
2012
2355
0.070
 Why?
DNA Replication
1
2010
252
0.070
 Why?
Glycoproteins
1
2010
353
0.070
 Why?
Polymorphism, Single-Stranded Conformational
1
2007
26
0.070
 Why?
Cell Differentiation
2
2008
2045
0.070
 Why?
Baltimore
1
2007
72
0.070
 Why?
CD8-Positive T-Lymphocytes
1
2013
917
0.060
 Why?
Tobacco Smoke Pollution
1
2009
227
0.060
 Why?
Smoking Cessation
1
2011
437
0.060
 Why?
Sequence Homology, Nucleic Acid
1
2007
156
0.060
 Why?
Linkage Disequilibrium
1
2007
249
0.060
 Why?
Prospective Studies
2
2011
8039
0.060
 Why?
Antigens, CD
1
2010
557
0.060
 Why?
Autophagy
2
2023
288
0.060
 Why?
DNA Primers
2
2008
507
0.060
 Why?
Superoxide Dismutase
1
2008
303
0.060
 Why?
Infant, Newborn
3
2007
6437
0.060
 Why?
ErbB Receptors
2
2019
635
0.060
 Why?
In Situ Hybridization, Fluorescence
1
2007
324
0.060
 Why?
Neoplasm Staging
3
2017
1468
0.060
 Why?
Haplotypes
1
2007
498
0.060
 Why?
Predictive Value of Tests
1
2011
2129
0.060
 Why?
Disease-Free Survival
1
2007
771
0.060
 Why?
Chromosomes, Human, Pair 21
1
2005
42
0.060
 Why?
Gene Knockdown Techniques
2
2021
335
0.060
 Why?
Preservation, Biological
1
2005
7
0.060
 Why?
Remission Induction
1
2005
309
0.050
 Why?
Liquid Biopsy
1
2024
15
0.050
 Why?
Cloning, Molecular
1
2005
535
0.050
 Why?
MicroRNAs
3
2019
689
0.050
 Why?
United States
3
2020
16115
0.050
 Why?
History, 21st Century
1
2025
220
0.050
 Why?
Child
5
2009
22680
0.050
 Why?
Tobacco Smoking
1
2024
26
0.050
 Why?
Child, Preschool
3
2005
11837
0.050
 Why?
History, 20th Century
1
2025
327
0.050
 Why?
Mice, Knockout
2
2021
3125
0.050
 Why?
Peptides
1
2010
993
0.050
 Why?
Chronology as Topic
1
2003
2
0.050
 Why?
Chromosome Breakage
1
2003
23
0.050
 Why?
Reproducibility of Results
2
2019
3424
0.050
 Why?
Artificial Gene Fusion
1
2002
4
0.050
 Why?
Restriction Mapping
1
2002
81
0.050
 Why?
Gene Expression
1
2008
1478
0.050
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2023
126
0.050
 Why?
Clone Cells
1
2003
264
0.050
 Why?
Mucins
1
2022
75
0.040
 Why?
Apoptosis
2
2021
2411
0.040
 Why?
Gene Rearrangement
1
2002
156
0.040
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2003
89
0.040
 Why?
Immunophenotyping
1
2003
320
0.040
 Why?
Promoter Regions, Genetic
1
2006
1247
0.040
 Why?
Chromosome Mapping
1
2002
509
0.040
 Why?
Cell Nucleolus
1
2021
19
0.040
 Why?
Adenosine
1
2022
256
0.040
 Why?
RNA Processing, Post-Transcriptional
1
2021
93
0.040
 Why?
Down-Regulation
1
2022
616
0.040
 Why?
Mutagenesis, Site-Directed
1
2021
374
0.040
 Why?
Aftercare
1
2022
222
0.040
 Why?
Glutaminase
1
2020
11
0.040
 Why?
Time Factors
1
2011
7171
0.040
 Why?
Fibrosis
1
2022
551
0.040
 Why?
Precision Medicine
1
2024
456
0.040
 Why?
RNA Precursors
1
2021
154
0.040
 Why?
Africa, Western
1
2019
21
0.040
 Why?
Mice, Nude
1
2021
678
0.040
 Why?
A549 Cells
1
2019
75
0.040
 Why?
Tumor Stem Cell Assay
1
2019
34
0.040
 Why?
Glutamine
1
2020
109
0.040
 Why?
Recurrence
1
2003
1142
0.040
 Why?
Exome
1
2020
227
0.040
 Why?
Nucleotides
1
2020
130
0.040
 Why?
Mice, SCID
1
2020
369
0.040
 Why?
Receptors, Antigen, T-Cell
1
2002
673
0.040
 Why?
Killer Cells, Natural
1
2022
480
0.040
 Why?
DNA Mutational Analysis
1
2019
409
0.040
 Why?
Tumor Burden
1
2020
324
0.030
 Why?
Incidence
2
2019
2915
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2020
167
0.030
 Why?
Survivors
1
2022
521
0.030
 Why?
Xenograft Model Antitumor Assays
1
2021
929
0.030
 Why?
STAT3 Transcription Factor
1
2019
205
0.030
 Why?
Cell Nucleus
1
2021
593
0.030
 Why?
Genetic Therapy
1
2019
316
0.030
 Why?
DNA-Binding Proteins
1
2005
1487
0.030
 Why?
B-Lymphocytes
1
2003
878
0.030
 Why?
Immunotherapy
1
2022
667
0.030
 Why?
Risk
1
2019
917
0.030
 Why?
Young Adult
3
2020
14192
0.030
 Why?
Transcription Factors
1
2005
1733
0.030
 Why?
Health Status Disparities
1
2019
321
0.030
 Why?
Positron Emission Tomography Computed Tomography
1
2017
117
0.030
 Why?
Adolescent
3
2009
22485
0.030
 Why?
Follow-Up Studies
2
2019
5426
0.030
 Why?
Pyrimidines
1
2019
520
0.030
 Why?
MAP Kinase Signaling System
1
2017
306
0.030
 Why?
Indoles
1
2019
508
0.030
 Why?
Neoplasm Metastasis
1
2017
691
0.030
 Why?
Survival Rate
1
2019
2093
0.030
 Why?
Leupeptins
1
2013
13
0.030
 Why?
Cell Survival
1
2017
1094
0.030
 Why?
Macrolides
1
2013
69
0.020
 Why?
Transduction, Genetic
1
2013
132
0.020
 Why?
Octamer Transcription Factor-3
1
2012
19
0.020
 Why?
Ligands
1
2014
667
0.020
 Why?
Binding Sites
1
2014
1313
0.020
 Why?
Neoplasm Proteins
1
2013
441
0.020
 Why?
Cohort Studies
2
2012
5992
0.020
 Why?
Disease Models, Animal
1
2021
4559
0.020
 Why?
Recombinant Proteins
1
2013
1367
0.020
 Why?
Mice, Inbred C57BL
1
2021
5989
0.020
 Why?
Cross-Sectional Studies
1
2022
5891
0.020
 Why?
Genetic Variation
1
2014
988
0.020
 Why?
Confidence Intervals
1
2010
331
0.020
 Why?
Early Detection of Cancer
1
2014
482
0.020
 Why?
Age Distribution
1
2010
403
0.020
 Why?
Sex Distribution
1
2010
387
0.020
 Why?
Small Cell Lung Carcinoma
1
2010
121
0.020
 Why?
Treatment Outcome
1
2024
11831
0.020
 Why?
Reference Values
1
2010
797
0.020
 Why?
Enzyme Stability
1
2008
73
0.020
 Why?
Homozygote
1
2008
200
0.020
 Why?
Neoplasm Recurrence, Local
1
2014
1150
0.020
 Why?
Linear Models
1
2010
848
0.020
 Why?
Odds Ratio
1
2010
1082
0.020
 Why?
Amino Acid Substitution
1
2008
303
0.020
 Why?
Colonic Neoplasms
1
2009
257
0.020
 Why?
Aged, 80 and over
1
2019
8326
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
975
0.010
 Why?
Cells, Cultured
1
2013
4127
0.010
 Why?
Erythroid-Specific DNA-Binding Factors
1
2005
17
0.010
 Why?
Comorbidity
1
2010
1659
0.010
 Why?
Environmental Exposure
1
2009
577
0.010
 Why?
Aneuploidy
1
2005
90
0.010
 Why?
Genome-Wide Association Study
1
2010
1378
0.010
 Why?
Retrospective Studies
1
2014
17269
0.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2005
1965
0.010
 Why?
Pine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)